方成;胡永成;陈晓鹏;

• 1:天津医科大学
• 2:天津市天津医院

摘要(Abstract)：

[目的]综述基因调控技术的最新研究进展,全面分析控释技术在骨组织工程中应用。[方法]广泛查阅近几年来国内外关于骨组织工程中基因表达调控的相关文献,并进行综述。[结果]基因调控技术能够严格调节成骨成血管因子表达,可以有效的避免生长因子过度表达,而导致有害的异位骨化或异常骨的形成以及异常血管或肿瘤血管的形成。[结论]生理状态下骨修复重建是多种生长因子在细胞内序贯表达,通过不同基因调控技术模拟生理状态下成血管和成骨因子序贯释放,将为研究血管化组织工程骨提供新策略。

关键词(KeyWords)： 骨组织工程;基因调控技术;骨缺损修复

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 方成;胡永成;陈晓鹏;

Email:

DOI:

参考文献(References)：

• [1]Young S,Patel ZS,Kretlow JD,et al.Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2on bone regeneration in a rat critical-size defect model[J].Tissue Eng Part A,2009,9:2347-2362.
• [2]Brown KV,Li B,Guda T,et al.Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2release[J].Tissue Eng Part A,2011,13-14:1735-1746.
• [3]Ramazanoglu M,Lutz R,Rusche P,et al.Bone response to biomimetic implants delivering BMP-2 and VEGF:an immunohistochemical study[J].J Craniomaxillofac Surg,2013,8:826-835.
• [4]Gossen M,Bujard H.Tight control of gene expression in mammalian cells by tetracycline-responsive promoters[J].Proc Natl Acad Sci USA,1992,12:5547-5551.
• [5]Bornkamm GW,Berens C,Kuklik-Roos C,et al.Stringent doxycycline-dependent control of gene activities using an episomal onevector system[J].Nucleic Acids Res,2005,16:137.
• [6]Deuschle U,Meyer WK,Thiesen HJ.Tetracycline-reversible silencing of eukaryotic promoters[J].Mol Cell Biol,1995,4:1907-1914.
• [7]Hasan MT,Schonig K,Berger S,et al.Long-term,noninvasive imaging of regulated gene expression in living mice[J].Genesis,2001,3:116-122.
• [8]Peng H,Usas A,Gearhart B,et al.Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4to achieve regulated bone formation[J].Mol Ther,2004,6:885-894.
• [9]Wang X,Cui F,Madhu V,et al.Combined VEGF and LMP-1 delivery enhances osteoprogenitor cell differentiation and ectopic bone formation[J].Growth Factors,2011,1:36-48.
• [10]Amara JF,Clackson T,Rivera VM,et al.A versatile synthetic dimerizer for the regulation of protein-protein interactions[J].Proc Natl Acad Sci USA,1997,20:10618-10623.
• [11]Sudomoina M,Latypova E,Favorova OO,et al.A gene expression system offering multiple levels of regulation:the Dual Drug Control(DDC)system[J].BMC Biotechnol,2004,4:9.
• [12]Lin C Y,Chang Y H,Sung L Y,et al.Long-term tracking of segmental bone healing mediated by genetically engineered ASCs:focuses on bone remodeling and potential side effects[J].Tissue Eng Part A,2013.
• [13]Czibik G.Complex role of the HIF system in cardiovascular biology[J].J Mol Med(Berl),2010,11:1101-1111.
• [14]Semenza GL.Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis[J].J Lab Clin Med,1998,3:207-214.
• [15]Su H,Arakawa-Hoyt J,Kan YW.Adeno-associated viral vectormediated hypoxia response element-regulated gene expression in mouse ischemic heart model[J].Proc Natl Acad Sci USA,2002,14:9480-9485.
• [16]Ye L,Zhang W,Su L P,et al.Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair[J].Biomaterials,2011,9:2424-2431.
• [17]Loboda A,Jazwa A,Wegiel B,et al.Heme oxygenase-1-dependent and-independent regulation of angiogenic genes expression:effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells[J].Cell Mol Biol(Noisy-le-grand),2005,4:347-355.
• [18]Pachori AS,Melo LG,Hart ML,et al.Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury[J].Proc Natl Acad Sci USA,2004,33:12282-12287.
• [19]Shi Y,Massague J.Mechanisms of TGF-beta signaling from cell membrane to the nucleus[J].Cell,2003,6:685-700.
• [20]Okamoto H,Matsumi Y,Hoshikawa Y,et al.Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells[J].PLoS One,2012,8:43800.
• [21]Huang K,Fu J,Zhou W,et al.MicroRNA-125b regulates osteogenic differentiation of mesenchymal stem cells by targeting Cbfbeta in vitro[J].Biochimie,2014,102:47-55.
• [22]Chen Q,Liu W,Sinha K M,et al.Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix[J].PLoS One,2013,3:58104.
• [23]Wu C H,Nusse R.Ligand receptor interactions in the Wnt signaling pathway in Drosophila[J].J Biol Chem,2002,44:41762-41769.
• [24]Zhang J,Tu Q,Bonewald LF,et al.Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1[J].J Bone Miner Res,2011,8:1953-1963.
• [25]Wang T,Xu Z.miR-27 promotes osteoblast differentiation by modulating Wnt signaling[J].Biochem Biophys Res Commun,2010,2:186-189.
• [26]Yin N,Lu R,Lin J,et al.Islet-1 promotes the cardiac-specific differentiation of mesenchymal stem cells through the regulation of histone acetylation[J].Int J Mol Med,2014,5:1075-1082.
• [27]Jing L,Jia Y,Lu J,et al.MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling[J].Neuroreport,2011,5:206-211.
• [28]Bae Y,Yang T,Zeng HC,et al.miRNA-34c regulates Notch signaling during bone development[J].Hum Mol Genet,2012,13:2991-3000.
• [29]Nakamura I,Takahashi N,Jimi E,et al.Regulation of osteoclast function[J].Mod Rheumatol,2012,2:167-177.
• [30]Huang C,Li H,Wu W,et al.Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3signaling pathway through SOCS1[J].Oncol Rep,2013,3:1223-1230.
• [31]Chen SY.MicroRNA-223:a double-edged sword in rheumatoid arthritis[J].Rheumatol Int,2014,2:285-286.
• [32]Rani SB,Rathod SS,Karthik S,et al.MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells[J].Neuro Oncol,2013,10:1302-1316.
• [33]Lee S,Yoon DS,Paik S,et al.MicroRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9[J].Stem Cells Dev,2014,15:1798-1808.
• [34]Sun F,Yang Q,Weng W,et al.Chd4 and associated proteins function as corepressors of Sox9 expression during BMP-2-induced chondrogenesis[J].J Bone Miner Res,2013,9:1950-1961.
• [35]Zhang R,Ma J,Yao J.Molecular mechanisms of the cartilage-specific microRNA-140 in osteoarthritis[J].Inflamm Res,2013,10:871-877.